Crohn's Disease and Malabsorption

From a western clinical standpoint, malabsorption in Crohn’s disease arises when inflammatory and structural processes compromise the intestine’s ability to absorb nutrients. The ileum is a key locus: active ileitis or surgical resection interrupts vitamin B12–intrinsic factor uptake and bile acid recycling. Excess bile acids that spill into the colon trigger secretory diarrhea and hinder micelle formation, impairing fat and fat‑soluble vitamin absorption. Jejunal involvement broadens the problem to include iron, folate, and macronutrients. Chronic transmural inflammation reduces absorptive surface area and increases permeability, and strictures or fistulas create stasis that fosters small intestinal bacterial overgrowth; these bacteria deconjugate bile acids and compete for vitamins, worsening diarrhea and steatorrhea. A subset of patients also exhibits exocrine pancreatic insufficiency, lowering digestive enzyme availability. Clinically, the pattern of deficiency often mirrors disease location: iron deficiency anemia is frequent across Crohn’s, while B12 deficiency is most common with ileal disease or resection. Vitamin D and other fat‑soluble vitamin deficiencies occur with extensive small‑bowel involvement or bile acid malabsorption, predisposing to bone loss. Zinc and magnesium depletion reflect persistent diarrhea. Diagnostic evaluation integrates symptom red flags (weight loss, steatorrhea, glossitis, neuropathy, fractures) with targeted testing: CBC, ferritin and transferrin saturation, B12/folate, 25‑hydroxyvitamin D, calcium, magnesium, zinc, and albumin or prealbumin. Fecal calprotectin helps differentiate active inflammation from functional symptoms; fecal elastase screens for exocrine pancreatic insufficiency; fecal fat quantification confirms steatorrhea; breath testing assesses SIBO; and SeHCAT or serum C4 (where available) supports a diagnosis of bile acid malabsorption. Endoscopy with ileoscopy and small‑bowel imaging (MR enterography) clarify extent and severity when treatment decisions hinge on anatomy. Management prioritizes mucosal healing—biologics and, in children, exclusive enteral nutrition—to restore absorptive capacity. Correcting iron deficiency (often with intravenous iron in active disease), parenteral or high‑dose oral B12, and vitamin D/calcium supports hematologic recovery and bone health. Treatable contributors such as bile acid diarrhea (bile acid sequestrants), SIBO (nonabsorbable antibiotics), and confirmed pancreatic insufficiency (enzyme replacement) can markedly reduce stool losses and improve nutrient uptake. Severe or postoperative malabsorption may require enteral tube feeds or, when the gut cannot be used effectively, parenteral nutrition. Ongoing monitoring every 3–6 months in active disease—and at least annually in remission—helps sustain gains and prevent complications.

Traditional frameworks interpret Crohn’s‑related malabsorption as a disruption of the body’s capacity to transform food into vital nourishment. In Traditional Chinese Medicine, patterns such as Spleen Qi deficiency and Damp‑Heat in the intestines reflect weakened digestive transformation alongside inflammatory congestion. Treatment aims to strengthen the Spleen (support assimilation), clear Damp/Heat (soothe inflamed bowels), and harmonize the Liver to modulate stress. Ayurveda similarly attributes malabsorption (grahani) to impaired Agni—digestive fire—aggravated by Pitta (inflammatory heat) and Kapha (congestion). The therapeutic emphasis is on calming the gut, simplifying the diet to easily digestible foods during flares, and gradually rebuilding digestive strength as inflammation abates. Herbal traditions contribute botanicals with anti‑inflammatory and mucosal‑supportive actions. Curcumin (from turmeric) and Boswellia serrata are classically used to quell intestinal irritation; early studies and clinical experience suggest potential benefits for symptom control, though robust trials in Crohn’s are limited compared with ulcerative colitis. Probiotic approaches are used to rebalance the microbiome, which in integrative practice may help select patients—particularly where SIBO contributes to symptoms—while acknowledging mixed evidence in Crohn’s. Nutrient repletion is also embraced: vitamin D and B12 are seen as crucial to restoring vitality, in coordination with clinical testing. Mind–body practices such as yoga, mindfulness meditation, and acupuncture are integrated to reduce stress reactivity, ease abdominal discomfort, and support appetite and rest—factors that indirectly improve nutritional status. In an integrative care plan, these traditional modalities complement, rather than replace, conventional therapies. As mucosal healing progresses with medical treatment, gentle dietary progression and individualized botanicals may support tolerance and quality of life. Practitioners emphasize close collaboration with gastroenterologists and dietitians to ensure that herbs or supplements do not interact with prescribed medications and that objective markers (e.g., iron indices, B12, vitamin D, bone density) guide the pace of nutritional rebuilding.